Malaria killed nearly half a million people in 2015, and 70% of this victims were young children. Malarial chemotherapy makes use of several drugs, each with its own pharmacological limitations, and with parasite resistance being the most challenging. People of low income nations often rely on traditional medicine as a treatment due to limited access to modern healthcare services. Despite uncertainties present in the outcome of traditional medicine, ethnomedicine approach has yielded important lead candidates. The investigation of medicinal plants utilized in the malaria endemic region yielded many antiplasmodial compounds with anthraquinone moiety. This paper describes natural anthraquinones extracted from medicinal plants utilized in traditional medicine for the treatment of malaria. In addition, the insight on structure-activity relationship and their mode of actions are also elaborated.
MambuL., GrellierP. (2007) Antimalarial compounds from Traditionally Used Medicinal Plants. In Bioactive Natural Products: Detection, Isolation and Structural Determination, ColegateS. M., and MolyneuxR. J. (Eds.), CRC Press, Florida, 491–530.
7.
PhillipsonJ.D., WrightC.W. (1991) Can ethnopharmacology contribute to the development of antimalarial agents?Journal of Ethnopharmacology, 32, 155–165.
8.
CowmanA.F., FooteS.J. (1990) Chemotherapy and drug resistance in malaria. International Journal for Parasitology, 20, 503–513.
9.
DharaniN., RukungaG., YenesewA., MboraA., MwauraL., DawsonI., JamnadassR. (2010) Common Antimalarial Trees and Shrubs of East Africa: a Description of Species and a Guide to Cultivation and Conservation Through Use, The World Agroforestry Centre (ICRAF), Nalrobi, Kenya, 1–96.
10.
OlliaroP. (2001) Mode of action and mechanisms of resistance for antimalarial drugs. Pharmacology & Therapeutics, 89, 207–219.
11.
BurkillI.H. (1966) A Dictionary of the Economic Products of Malay Peninsular, Ministry of Agriculture, Kuala Lumpur.
12.
KoyamaJ. (2006) Anti-Infective Quinone Derivatives of Recent Patents. Recent Patents on Anti-Infective Drug Discovery, 1, 113–125.
13.
KoyamaJ., NisinoY., MoritaI., KobayashiN., OsakaiT., TokudaH. (2008) Correlation between Reduction Potentials and Inhibitions of Eipstein-Barr Virus Activation by Anthraquinone Derivatives. Bioorganic & Medicinal Chemistry Letters, 18, 1406–1409.
JacqueminD., WatheletV., PreatJ., PerpeteE.A. (2007) Ab initio tools for the accurate prediction of the visible spectra of anthraquinones. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 67, 334–341.
18.
FainV.Y., ZaitsevB.E., RyabovM.A. (2006) Tautomerism of anthraquinones: IV. 1-Hydroxy-9,10-anthraquinone and its substituted derivatives. Russian Journal of Organic Chemistry, 42, 1469–1472.
19.
SchorkhuberM., RichterM., DutterA., SontagG., MarianB. (1998) Effect of anthraquinone-laxatives on the proliferation and urokinase secretion of normal, premalignant and malignant colonic epithelial cells. European Journal of Cancer, 34, 1091–1098.
20.
BerettaG.L., ZuninoF. (2007) Molecular Mechanisms of Anthracycline Activity. In Anthracycline Chemistry and Biology II, KrohnK. (Ed.), Springer, Heildelberg, 1–20.
21.
LaiJ-M, ChangJ.T., WenC-L, HsuS-L. (2009) Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. European Journal of Pharmacology, 623, 1–9.
22.
Sadeghi-AliabadiH., TabarzadiM., ZarghiA. (2004) Synthesis and cytotoxic evaluation of two novel anthraquinone derivatives. Il Farmaco, 59, 645–649.
23.
SchenckL.W., KunaK., FrankW., AlbertA., AscheC., KucklaenderU. (2006) 1,4,9,10-Anthradiquinone as precursor for antitumor compounds. Bioorganic & Medicinal Chemistry, 14, 3599–3614.
24.
SchripsemaJ., DagninoD. (1996) Elucidation of the Substitution Pattern of 9,10-Anthraquinones through the Chemical Shift of Peri-Hydroxyl Protons. Phytochemistry, 42, 177–184.
25.
SchripsemaJ., Ramos-ValdiviaA., VerpoorteR. (1999) Robustaquinones, novel anthraquinones from an elicited Cinchona robusta suspension culture. Phytochemistry, 51, 55–60.
26.
HanY-S, der HeidenR.V., VerpoorteR. (2001) Biosynthesis of Anthraquinones in Cell Cultures of the Rubiaceae. Plant Cell, Tissue and Organ Culture, 67, 201–220.
27.
DagneE., YenesewA., AsmellashS., DemissewS., MaviS. (1994) Anthraquinones, pre-anthraquinones and isoeleutherol in the roots of Aloe species. Phytochemistry, 35, 401–406.
28.
Van WykB-E, YenesewA., DagneE. (1995) Chemotaxonomic survey of anthraquinones and pre-anthraquinones in roots of Aloe species. Biochemical Systematics and Ecology, 23, 267–275.
29.
HanY-S, HeijdenRvd, LefeberA.W.M., ErkelensC., VerpoorteR. (2002) Biosynthesis of anthraquinones in cell cultures of Cinchona ‘Robusta’ proceeds via the methylerythritol 4-phosphate pathway. Phytochemistry, 59, 45–55.
30.
EckhardL. (1973) Biosynthesis of morindone and alizarin in intact plants and cell suspension cultures of Morinda citrifolia.Phytochemistry, 12, 1669–1674.
31.
DewickP.M. (2002) Medicinal Natural Product: A Biosynthetic Approach, John Wiley & Sons, West Sussex, 7–34.
32.
DerksenG.C.H., Van BeekT.A. (2002) Rubia tinctorum L. In Studies in Natural Products Chemistry, Atta-ur-Rahman (Ed.), Elsevier, Amsterdam, 629–684.
33.
BaoL., QinL., LiuL., WuY., HanT., XueL., ZhangQ. (2011) Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro.Chemico-Biological Interactions, 194, 97–105.
34.
EeG.C.L., WenY.P., SukariM.A., GoR., LeeH.L. (2009) A new anthraquinone from Morinda citrifolia roots. Natural Product Research: Formerly Natural Product Letters, 23, 1322–1329.
FengZ-M, JiangJ-S, WangY-H, ZhangP-C. (2005) Anthraquinones from the Roots of Prismatomeris tetrandra.Chemical Pharmaceutical Bulletin, 53, 1330–1332.
37.
KanokmedhakulK., KanokmedhakulS., PhatchanaR. (2005) Biological activity of Anthraquinones and Triterpenoids from Prismatomeris fragrans.Journal of Ethnopharmacology, 100, 284–288.
MuthauraC.N., RukungaG.M., ChhabraS.C., MungaiG.M., and NjagiE.N.M. (2007) Traditional antimalarial phytotherapy remedies used by the Kwale community of the Kenyan Coast. Journal of Ethnopharmacology, 114, 377–386.
44.
EndaleM., EkbergA., AlaoJ.P., AkalaH.M., NdakalaA., SunnerhagenP., ErdélyiM., YenesewA. (2013) Anthraquinones of the roots of Pentas micrantha.Molecules, 18, 311–321.
AbdissaD., GeletaG., BachaK., AbdissaN. (2017) Phytochemical investigation of Aloe pulcherrima roots and evaluation for its antibacterial and antiplasmodial activities. PLoS ONE, 12, e0173882.
50.
KumarS., YadavM., YadavA., Rohilla, YadavJ.P. (2017) Antiplasmodial potential and quantification of aloin and aloe-emodin in Aloe vera collected from different climatic regions of India. BMC Complementary and Alternative Medicine, 17, 1–10
51.
OnegiB., KraftC., KöhlerI., FreundM., Jenett-SiemsK., SiemsK., BeyerG., MelzigM.F., BienzleU., EichE. (2002) Antiplasmodial activity of naphthoquinones and one anthraquinone from Stereospermum kunthianum.Phytochemistry, 60, 39–44.
52.
NjorogeG.N., BussmannR.W. (2006) Diversity and utilization of antimalarial ethnophytotherapeutic remedies among the Kikuyus (Central Kenya). Journal of Ethnobiology and Ethnomedicine, 2, 8.
53.
HouY., CaoS., BrodieP.J., CallmanderM.W., RatovosonF., RakotobeE., RasamisonV.E., MichelRatsimbason, AlumasaJ.N., RoepeP.D., KingstonD.G.I. (2010) Antiproliferative and antimalarial anthraquinones of Scutia myrtina from the Madagascar forest. Bioorganic & Medicinal Chemistry, 1, 2871–2876.
54.
BringmannG., MencheD., BezabihM., AbegazB.M., KaminskyR. (1999) Antiplasmodial activity of knipholone and related natural phenylanthraquinones. Planta Medica, 65, 757–758.
55.
AbegazB.M., BezabihM., MsutaT., BrunR., MencheD., MuhlbacherJ., BringmannG. (2002) Gaboroquinones A and B and 4'-O-demethylknipholone-4'-O-β-D-glucopyranoside, Phenylanthraquinones from the Roots of Bulbine frutescens.Journal of Natural Products, 65, 1117–1121.
56.
BringmannG., Mutanyatta-ComarJ., MaksimenkaK., WanjohiJ.M., HeydenreichM., BrunR., MüllerW.E.G., PeterM.G., MidiwoJ.O., YenesewA. (2008) Joziknipholones A and B: The first dimeric phenylanthraquinones, from the roots of Bulbine frutescens.Chemistry - A European Journal, 14, 1420–1429.
57.
BringmannG., MencheD., BrunR., MsutaT., AbegazB. (2002) Bulbine-knipholone, a new, axially chiral phenylanthraquinone from Bulbine abyssinica (Asphodelaceae): Isolation, structural elucidation, synthesis, and antiplasmodial activity. European Journal of Organic Chemistry, 1107–1111.
AbdissaN., InduliM., AkalaH.M., HeydenreichM., MidiwoJ.O., NdakalaA., YenesewA. (2013) Knipholone cyclooxanthrone and an anthraquinone dimer with antiplasmodial activities from the roots of Kniphofia foliosa.Phytochemistry Letters, 6, 241–245.
60.
DaiY., HarinantenainaL., BowmanJ.D., Da FonsecaI.O., BrodieP.J., GoetzM., CasseraM.B., KingstonD.G.I. (2014) Isolation of antiplasmodial anthraquinones from Kniphofia ensifolia, and synthesis and structure-activity relationships of related compounds. Bioorganic and Medicinal Chemistry, 22, 269–276.
61.
KopaT.K., TchindaA.T., TalaM.F., ZofouD., JumbamR., WaboH.K., TitanjiV.P.K., FrédérichM., TanN-H, TaneP. (2014) Antiplasmodial anthraquinones and hemisynthetic derivatives from the leaves of Tectona grandis (Verbenaceae). Phytochemistry Letters, 8, 41–45.
OsmanC.P., IsmailN.H., WidyawaruyantiA., ImranS., TumewuL., ChooC-Y, SharinahI. (2018) Evaluation of a series of 9,10-anthraquinones as antiplasmodial agents. Letters in Drug Design & Discovery, 16, Accepted.
64.
GutierrezP.L. (2001) The metabolism of quinone-containing alkylating agents: free radical production and measurement. Frontiers in Biosscience, 5, 629–638.
65.
WinterR.W., CornellK.A., JohnsonL.L., IgnatushchenkoM.V., HinrichsD.J., RoscoeM.K. (1996) Potentiation of the antimalarial agents Rufigallol. Antimicrobial Agents Chemotherapy, 40, 1408–1411.
66.
El HeigaL.A., KatzhendlerJ., GeanK.F., BachrachU. (1990) Antimalarial activity of substituted anthraquinones. Biochemical Pharmacology, 39, 1620–1623.
67.
KumarS., GuhaM., ChoubeyV., MaityP., BandyopadhyayU. (2007) Antimalarial drugs inhibiting hemozoin (β-hematin) formation: A mechanistic update. Life Sciences, 80, 813–828.
68.
RadfarA., DiezA., BautistaJ.M. (2008) Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum.Free Radical Biology and Medicine, 44, 2034–2042.
69.
IgnatushchenkoM.V., WinterR.W., BachingerH.P., HinrichsD.J., RiscoeM.K. (1997) Xanthones as Antimalarial Agents; Studies of a Possible Mode of Action.FEBS Letters, 409, 67–73.
70.
RathoreD., JaniD., NagarkattiR., and KumarS. (2006) Heme detoxification and antimalarial drugs - Known mechanisms and future prospects. Drug Discovery Today: Therapeutic Strategies, 3, 153–158.
71.
EganT.J., ChenJY-J, de VilliersK.A., MabothaT.E., NaidooK.J., NcokaziK.K., LangfordS.J., McNaughtonD., PandiancherriS., WoodB.R. (2006) Haemozoin (beta-haematin) Biomineralization Occurs by Self-assembly Near the Lipid/Water Interface. FEBS Letters, 580, 5105–5110.
72.
OlliaroP.L., YuthavongY. (1999) An Overview of Chemotherapeutic Targets for Antimalarial Drug Discovery. Pharmacology & Therapeutics, 81, 91–110.
73.
LinB.C., HarrisD.R., KirkmanL.M.D., PerezA.M., QianY., SchermerhornJ.T., HongM.Y., WinstonD.S., XuL., LieberA.M., HamiltonM., BrandtG.S. (2017) The anthraquinone emodin inhibits the non-exported FIKK kinase from Plasmodium falciparum.Bioorganic Chemistry, 75, 217–223.
74.
LinB.C., HarrisD.R., KirkmanL.M.D., PerezA.M., QianY., SchermerhornJ.T., HongM.Y., WinstonD.S., XuL., BrandtG.S. (2017) FIKK Kinase, a Ser/Thr Kinase Important to Malaria Parasites, Is Inhibited by Tyrosine Kinase Inhibitors. ACS Omega, 2, 6605–6612.
